Condition
AIDS-related Lymphoblastic Lymphoma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownIntravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin LymphomaNCT01775475 · 2016-09-15
COMPLETEDGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaNCT01769911 · 2015-02-01
WITHDRAWNRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsNCT01158274 · 2010-06-01
COMPLETEDSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNCT00890747 · 2009-08-01
COMPLETEDTopotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous TreatmentNCT00005811 · 2000-04-01
COMPLETEDFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerNCT00112593 · 1999-11-01
COMPLETEDCommon interventions
laboratory biomarker analysisOTHER6etoposideDRUG2peripheral blood stem cell transplantationPROCEDURE2autologous hematopoietic stem cell transplantationPROCEDURE1capecitabineDRUG1carmustineDRUG1cyclophosphamideDRUG1cyclosporineDRUG1cytarabineDRUG1doxorubicin hydrochlorideDRUG1fludarabine phosphateDRUG1gamma-secretase/Notch signalling pathway inhibitor RO4929097DRUG1lomustineDRUG1melphalanDRUG1mycophenolate mofetilDRUG1O6-benzylguanineDRUG1pharmacological studyOTHER1prednisoneDRUG1procarbazine hydrochlorideDRUG1sunitinib malateDRUG1topotecan hydrochlorideDRUG1total-body irradiationRADIATION1vincristine sulfateDRUG1
Leading sponsors
Trial status mix
COMPLETED5
WITHDRAWN1
Phase mix
NA2
PHASE12
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.